In hepatocellular carcinoma, elevated RUNX1 levels have been shown to upregulate COL4A1 expression, thereby activating the FAK-Src signaling pathway and promoting the proliferation, migration, and invasion of hepatocellular carcinoma cells [58]. This evidence concerns the gene COL4A1 and hepatocellular carcinoma.